COVID-19: what we are doing

Find out what ELIXIR members are doing to support the fight against COVID-19 in their countries. For a list of services ELIXIR is providing for COVID-19 research see the ELIXIR support to COVID-19 page.

ELIXIR Belgium×

ELIXIR Czech Republic×

ELIXIR Cyprus×

  • Information available soon.

ELIXIR Estonia×

ELIXIR Denmark×

  • Established a feature in the software registry to allow scientists to search for the most suitable software for COVID-19-related work.

ELIXIR Finland×

  • Prioritising access to national cloud and computing facilities for COVID-19 research projects.
  • Mobilised resources for the virtual COVID-19 BioHackathon.

ELIXIR France×

  • Formed a COVID-19 Task Force with national experts in bioinformatics and infrastructure provision.
  • Created a website listing the national computing infrastructures and workflows. See the IFB website.

ELIXIR Germany×

ELIXIR Greece×

ELIXIR Hungary×

  • Developed a timeline map to track the spreading of the disease to predict the outcome of the outbreak in each country.
  • Collaborating in EBI’s Data Hubs.
  • Developing COVIDoutcome, a portal to link mutation and outcome.
  • Collecting virus and blood samples from patients to investigate immune system response (n=20,000).

ELIXIR Ireland×

ELIXIR Israel×

  • Published research on COVID-19 - see the bioRxiv paper.
  • Contributed to a web page dedicated to the Coronavirus Disease 2019 on Proteopedia—the free 3D-encyclopedia of proteins and other biomolecules.


  • Created a national COVID-19 Data Portal
  • Mobilised the national compute resources to support virtual the COVID-19 BioHackathon and for on-demand Galaxy workflow support. See the Laniakea website. Release of CorGAT, a Galaxy based workflow with custom tools and utilities for the annotation of genomic variants.
  • Webinars and tutorials about Open Science and COVID-19 in collaboration with OpenAIRE, RDA, EOSC-Pillar and EOSC-Life. “Ask Me Anything” event for younger people and high-school students.
  • Intrinsically disordered proteins of SARS-CoV-2 have been manually curated and added to DisProt, see the dedicated blog post. Curation in the MINT database of molecular interactions involving proteins from SARS-CoV2, SARS and other members of the Coronaviridae family. Signor 2.0 database collected and annotated information on cellular pathways that are modulated by SARS-COV-2 infection.
  • Microbiome investigation on COVID-19 positive swab samples by applying a meta-transcriptomic approach.

ELIXIR Luxembourg×

ELIXIR Netherlands×

ELIXIR Norway×

ELIXIR Portugal×

ELIXIR Slovenia×

  • Created a national COVID-19 Data Portal
  • Developing a COVID-19 registry of patient data to enable online data collection and provide (some) compute resources for national and international research.


  • Created a national COVID-19 data portal.
  • Created a website that gathers all the efforts of ELIXIR Spain and TransBioNet members. See the Spanish National Bioinformatics Institute (INB) website.
  • Collaborative work on COVID-19 Viral Beacon, a platform allowing researchers to browse SARS-CoV-2 variability at the genome, amino acid, structural and motif level.
  • ELIXIR-ES RIR resources including the COVID-19 customisation of the text mining resource DisGeNET to identify mentions of genes, diseases, variants and phenotypes, COVID-19 and SARS-CoV-2 virus, and the 3DBIONOTES-COVID19 tool that brings together structural and functional information on SARS-CoV-2 proteome.
  • Availability of CoV-Hipathia, a web tool implementing mechanistic analysis of COVID-19-related pathways from gene expression data. CoV-Hipathia together with DisGeNet are part of COVID-19 Disease Maps, the collaborative effort led by UNILU to create, update and extend a Disease Map focused on COVID-19.

ELIXIR Sweden×

  • Created a national COVID-19 Data Portal
  • Planning the collection of human sequences (e.g. proteomics, serology) to store it securely in a local instance of the European Genome phenome Archive (EGA).

ELIXIR Switzerland×

  • Running databases and tools for COVID-19 research.
  • Created a dedicated webpage to compile all related resources. See the SIB website.
  • Centralizing and analysing, on its Swiss Pathogen Surveillance Platform SPSP, all SARS-CoV-2 sequenced data from Switzerland, to be shared with ENA and GISAID and to support the work of the national COVID-dedicated task force (pending funding approval).
  • Developed outreach resources for schools (in French) and lay audiences (in English and French) to understand the biology of the coronavirus.


Portugal Netherlands Belgium Italy Greece Finland Germany Sweden Norway Ireland Switzerland Czech Republic Hungary Estonia France Luxembourg Slovenia UK Denmark Cyprus Spain Israel
COVID-19 Data Portal

The EBI and the European Commission have launched the European COVID-19 Data Portal. This enables the rapid collection and sharing of relevant data, in an effort to accelerate coronavirus research.


In October 2021, the BY-COVID project started. Coordinated by ELIXIR, and making use of the COVID-19 Portal, this three-year project aims to make SARS-CoV-2 and other infectious disease data easier to find and share. It is hoped that this project will enable researchers and policy makers to respond quicker to new infectious diseases.